260 related articles for article (PubMed ID: 21394201)
1. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
Wu W; de Folter S; Shen X; Zhang W; Tao S
PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
[TBL] [Abstract][Full Text] [Related]
2. Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites.
Wu W; Huang X; Cheng J; Li Z; de Folter S; Huang Z; Jiang X; Pang H; Tao S
Mol Biol Evol; 2011 Jan; 28(1):501-11. PubMed ID: 20724380
[TBL] [Abstract][Full Text] [Related]
3. MEF2B is a potent transactivator expressed in early myogenic lineages.
Molkentin JD; Firulli AB; Black BL; Martin JF; Hustad CM; Copeland N; Jenkins N; Lyons G; Olson EN
Mol Cell Biol; 1996 Jul; 16(7):3814-24. PubMed ID: 8668199
[TBL] [Abstract][Full Text] [Related]
4. Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment.
Wu Y; Dey R; Han A; Jayathilaka N; Philips M; Ye J; Chen L
J Mol Biol; 2010 Mar; 397(2):520-33. PubMed ID: 20132824
[TBL] [Abstract][Full Text] [Related]
5. [Properties comparing and evolutionary analysis of MEF2 of Homo sapiens based on bioinformatic methods].
Guo XJ
Yi Chuan; 2011 Sep; 33(9):975-81. PubMed ID: 21951798
[TBL] [Abstract][Full Text] [Related]
6. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
Zhu B; Ramachandran B; Gulick T
J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
[TBL] [Abstract][Full Text] [Related]
7. Common Carp
He M; Zhou D; Ding NZ; Teng CB; Yan XC; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374988
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
Zhu B; Gulick T
Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
Molkentin JD; Li L; Olson EN
J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
[TBL] [Abstract][Full Text] [Related]
10. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
Molkentin JD; Black BL; Martin JF; Olson EN
Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
[TBL] [Abstract][Full Text] [Related]
12. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes.
Thai MV; Guruswamy S; Cao KT; Pessin JE; Olson AL
J Biol Chem; 1998 Jun; 273(23):14285-92. PubMed ID: 9603935
[TBL] [Abstract][Full Text] [Related]
13. The molecular characterization and temporal-spatial expression of myocyte enhancer factor 2 genes in the goat and their association with myofiber traits.
Chen L; Cheng B; Li L; Zhan S; Wang L; Zhong T; Chen Y; Zhang H
Gene; 2015 Jan; 555(2):223-30. PubMed ID: 25447896
[TBL] [Abstract][Full Text] [Related]
14. Myocyte enhancer factor 2A is transcriptionally autoregulated.
Ramachandran B; Yu G; Li S; Zhu B; Gulick T
J Biol Chem; 2008 Apr; 283(16):10318-29. PubMed ID: 18073218
[TBL] [Abstract][Full Text] [Related]
15. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila.
Nguyen T; Wang J; Schulz RA
Differentiation; 2002 Oct; 70(8):438-46. PubMed ID: 12366381
[TBL] [Abstract][Full Text] [Related]
16. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23.
Hobson GM; Krahe R; Garcia E; Siciliano MJ; Funanage VL
Genomics; 1995 Oct; 29(3):704-11. PubMed ID: 8575763
[TBL] [Abstract][Full Text] [Related]
17. Global characterization of interferon regulatory factor (IRF) genes in vertebrates: glimpse of the diversification in evolution.
Huang B; Qi ZT; Xu Z; Nie P
BMC Immunol; 2010 May; 11():22. PubMed ID: 20444275
[TBL] [Abstract][Full Text] [Related]
18. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
Kang J; Gocke CB; Yu H
BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
[TBL] [Abstract][Full Text] [Related]
20. DNA binding specificity determinants in MADS-box transcription factors.
Nurrish SJ; Treisman R
Mol Cell Biol; 1995 Aug; 15(8):4076-85. PubMed ID: 7623803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
